Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

被引：0
|
作者：
Hisaharu Shikata
Yoshihiro Yakushijin
Jun Yamanouchi
Taichi Azuma
Masaki Yasukawa
机构：
[1] Ehime University Graduate School of Medicine,Department of Bioregulatory Medicine, Ehime University Hospital
[2] Ehime University Graduate School of Medicine,Cancer Center, Ehime University Hospital
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Hematological nadir; Febrile neutropenia (FN); G-CSF prophylaxis; R-CHOP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 185
页数：7
相关论文
共 50 条
  • [31] Impact of salvage treatment modalities in patients with positive FDG-PET/CT after R-CHOP chemotherapy for aggressive B-cell non-Hodgkin lymphoma
    Chin, Vicky
    Fulham, Michael
    Hertzberg, Mark
    Jackson, Michael
    Lindeman, Robert
    Brighton, Timothy
    Kidson-Gerber, Giselle
    Wegner, Eva A.
    Cheung, Carol
    MacCallum, Susan
    Williams, Janet
    Thompson, Stephen R.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2018, 62 (03) : 432 - 439
  • [32] Primary Cutaneous Diffuse Large B-cell Lymphoma Successfully Treated With R-CHOP Chemotherapy
    Alghamdi, Wafa M.
    Aljehani, Fawaz H.
    Alharthi, Abdullah M.
    Bakhsh, Reda I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [33] Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma
    Lyman, GH
    Delgado, DJ
    CANCER, 2003, 98 (11) : 2402 - 2409
  • [34] Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas
    Kansara, Roopesh
    Connors, Joseph M.
    Savage, Kerry J.
    Gerrie, Alina S.
    Scott, David W.
    Slack, Graham W.
    Gascoyne, Randy D.
    Sehn, Laurie H.
    Villa, Diego
    HAEMATOLOGICA, 2016, 101 (10) : E411 - E414
  • [35] Use of the Lymphgen Tool in a Cohort of Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP
    Jackson, Ryan
    Perry, Anamarija
    Herrera, Alex
    Bedell, Victoria
    Murata-Collins, Joyce
    Rahimi, Nina
    Pillai, Raju
    Chan, Wing
    Weisenburger, Dennis
    Song, Joo
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 845 - 846
  • [36] Use of the Lymphgen Tool in a Cohort of Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP
    Jackson, Ryan
    Perry, Anamarija
    Herrera, Alex
    Bedell, Victoria
    Murata-Collins, Joyce
    Rahimi, Nina
    Pillai, Raju
    Chan, Wing
    Weisenburger, Dennis
    Song, Joo
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 845 - 846
  • [37] ESTIMATION OF G-CSF EFFECTIVENESS IN REDUCING NEUTROPENIA HOSPITALIZATION AMONG NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS TREATED WITH ANTHRACYCLINE-BASED CHEMOTHERAPY
    Pan, X.
    Brooks, J.
    VALUE IN HEALTH, 2010, 13 (03) : A25 - A25
  • [38] Predictors of G-CSF Prophylaxis in the First Cycle of Chemotherapy in Non-Hodgkin's Lymphoma Patients
    Asubonteng, Julius
    Wetten, Sally
    Lugtenburg, Pieternella J.
    DeCosta, Lucy
    Szabo, Zsolt
    Page, John H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 60 - 61
  • [39] Progress in the Research of Pneumocystis Pneumonia in Non-Human Immunodeficiency Virus-Infected Non-Hodgkin's B-Cell Lymphoma Treated With R-CHOP
    Zhou, Fengping
    Jin, Shenhe
    Zhang, Jin
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 (04) : 1169 - 1172
  • [40] Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494)
    Morrison, Vicki A.
    Weller, Edie A.
    Habermann, Thomas M.
    Li, Shuli
    Fisher, Richard I.
    Cheson, Bruce D.
    Peterson, Bruce A.
    LEUKEMIA & LYMPHOMA, 2017, 58 (08) : 1814 - 1822
12345